Why RZLT? Rezolute, Inc. Analysis, Price & AI Insights | Whystock
RZLT
$3.30+0.10 (+3.13%)
Market ClosedLast close May 1
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.